LOBE.CN

Lobe Sciences Ltd.
Canadian SecCADEQUITY Healthcare DELAYED
Last price
0.07
▼ 0.01 (12.50%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.07
Prev close
0.08
Day high
0.07
Day low
0.07
Volume
12.00K
Market cap
$21.57M
P/E (TTM)
52W range
0.03 – 0.18

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-6.67% -5.3%
1M
-22.22% -26.0%
3M
-39.13% -42.2%
6M
+7.69% -3.4%
YTD
+55.56% +43.3%
1Y
+27.27% +7.3%
3Y
+133.33% +59.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on LOBE.CN open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
196.07M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 1, 26
Quality Chemical Laboratories LLC
Senior Officer of Issuer
0 Direct
Aug 1, 26
Quality Chemical Laboratories LLC
Senior Officer of Issuer
35.85M Direct
Jul 24, 26
Clearway Global LLC
10% Security Holder of Issuer
80.15M Direct
Jul 24, 26
Dariani (Maghsoud)
Senior Officer of Issuer
6.41M Direct
Jul 24, 26
Jacobson (Harry R)
Director of Issuer
3.56M Direct
Jul 24, 26
Mastrodonato (Marco)
Director of Issuer
3.75M Direct
Jul 24, 26
Mirza (Rahimani)
Senior Officer of Issuer
1.00M Direct
Jul 24, 26
Ramjeet (Wesley)
Director of Issuer
3.66M Direct
Jul 24, 26
Sancilio (Carolyn)
10% Security Holder of Issuer
16.65M Indirect
Jul 24, 26
Sancilio (Carolyn)
10% Security Holder of Issuer
7.72M Indirect
Jul 24, 26
Sancilio (Carolyn)
10% Security Holder of Issuer
2.32M Direct
Jul 24, 26
Sancilio (Frederick D)
10% Security Holder of Issuer
12.44M Direct
Jul 24, 26
Sancilio (Frederick D)
10% Security Holder of Issuer
7.72M Indirect
Jul 24, 26
Sancilio (Frederick D)
10% Security Holder of Issuer
16.65M Indirect
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
Clearway Global LLC
10% Security Holder of Issuer 102.23M Compensation for services
Dariani (Maghsoud)
Senior Officer of Issuer 7.46M Compensation for services
Goulburn (Charles F)
Director of Issuer 4.79M Compensation for services
Jacobson (Harry R)
Director of Issuer 9.32M Compensation for services
Mastrodonato (Marco)
Director of Issuer 3.75M Compensation for services
Mirza (Rahimani)
Senior Officer of Issuer 1.00M Compensation for services
Quality Chemical Laboratories LLC
Senior Officer of Issuer 0 Opening Balance-Initial SEDI Report
Ramjeet (Wesley)
Director of Issuer 10.33M Compensation for services
Sancilio (Carolyn)
10% Security Holder of Issuer Compensation for services
Sancilio (Frederick D)
10% Security Holder of Issuer 12.44M Compensation for services

Fundamentals

TTM · reported
Market cap$21.57M
Enterprise value$18.02M
Revenue (TTM)
Gross profit
EBITDA
Net income$-5.56M
EPS (TTM)$-0.04
Free cash flow$-3.89M
Total cash$5.21M
Total debt$338.40K
Book value / share$0.01
Shares outstanding308.18M
Float108.97M
Short % of float
Dividend yield
Beta (5Y)-0.06

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book10.00
EV / revenue
EV / EBITDA
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-214.20%
Return on assets-63.32%
Debt / equity10.56
Current ratio2.38
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $0$136.21K$840.53K$0 -100.0%
Operating revenue $0$136.21K$840.53K$0 -100.0%
Cost of revenue $0$1.76K$24.01K$0 -100.0%
Gross profit $0$134.45K$816.52K$0 -100.0%
Research & development $641.12K$386.24K$1.25M$418.34K +66.0%
Selling, general & admin $3.54M$1.78M$2.88M$3.69M +98.6%
Total operating expense $4.18M$2.25M$4.18M$4.12M +85.6%
Operating income -$4.18M-$2.12M-$3.36M-$4.12M -97.4%
Net interest income -$577.92K-$186.65K-$38.64K$0 -209.6%
Pre-tax income -$4.86M-$4.39M-$4.50M-$12.25M -10.8%
Tax provision $0$33.00K$205.00K$0 -100.0%
Net income -$4.43M-$4.42M-$4.71M-$12.25M -0.2%
Net income to common -$4.43M-$4.42M-$4.71M-$12.25M -0.2%
Basic EPS -0.03-0.04-0.05-0.32 +25.0%
Diluted EPS -0.03-0.04-0.05-0.32 +25.0%
EBIT -$4.27M-$4.20M-$4.46M-$12.25M -1.5%
EBITDA -$4.27M-$4.12M-$4.42M-$12.24M -3.6%
Basic shares 138.72M122.13M104.35M37.86M +13.6%
Diluted shares 138.72M122.13M104.35M37.86M +13.6%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders63.62%
Held by institutions0.00%
Institutions holding0
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.08
-9.09% from price
SMA 20
0.08
-11.11% from price
SMA 50
0.09
-21.52% from price
SMA 100
0.10
-28.97% from price
SMA 200
0.08
-7.44% from price
EMA 12
0.08
-8.70% from price
EMA 26
0.08
-14.46% from price
EMA 50
0.09
-20.09% from price
RSI (14)
42.5
Neutral
MACD (12,26,9)
-0.01
Hist 0.00
ATR (14)
0.01
14.29% of price
Realised vol 30D
163.6%
Annualised
Bollinger upper
0.09
20, 2σ
Bollinger lower
0.06
20, 2σ
50 / 200 cross
Golden
0.09 vs 0.08
Trend bias
Below 200
-7.44%

Options chain

Account required
ExpirySpot 0.07
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.21
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
163.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-51.7%
Peak to trough
Max drawdown 5Y
-97.8%
Peak to trough
ATR 14
0.01
14.29% of price
Beta (reported)
-0.06
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
692
Prior 417
Change vs prior
+65.9%
Shorts adding
% of float
% of shares out
0.00%
Against total outstanding
Days to cover
0.1
Liquid
Float
108.97M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Dividends & splits

Declared · from the issuer
Forward rate
Forward yield
5-year avg yield
Payout ratio0.00%
Ex-dividend date
Next pay date
Last split1:6
Split dateJun 10, 2022

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.